Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data From Two Large US Cancer Centres
Data from two large cancer centres in the United States have shown that the COVID-19 pandemic caused substantial disruption to clinical trials for cancer treatment and care.